Brind.

aTyr Pharma and MoonLake Immunotherapeutics are small-cap biotech stocks.

1 report, 1 independent Updated Aug 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

aTyr Pharma

Keep exploring

The entities involved

aTyr Pharma
company in San Diego, United States
- Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.Sun 04:59

Coverage

Newest first; wire copies grouped

Aug 27Motley Fool2 Small-Cap Biotech Stocks Well Positioned for a Breakout Pulmonary sarcoidosis patients could soon get the treatment option they've been waiting for from aTyr Pharma. MoonLake Immunotherapeutics is